Anne Linde Mak
Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease
Mak, Anne Linde; Lee, Jenny; van Dijk, Anne-Marieke; Vali, Yasaman; Aithal, Guruprasad P.; Schattenberg, Jörn M.; Anstee, Quentin M.; Brosnan, M. Julia; Zafarmand, Mohammad Hadi; Ramsoekh, Dewkoemar; Harrison, Stephen A.; Nieuwdorp, Max; Bossuyt, Patrick M.; Holleboom, Adriaan G.
Authors
Jenny Lee
Anne-Marieke van Dijk
Yasaman Vali
Professor GURUPRASAD AITHAL Guru.Aithal@nottingham.ac.uk
PROFESSOR OF HEPATOLOGY
Jörn M. Schattenberg
Quentin M. Anstee
M. Julia Brosnan
Mohammad Hadi Zafarmand
Dewkoemar Ramsoekh
Stephen A. Harrison
Max Nieuwdorp
Patrick M. Bossuyt
Adriaan G. Holleboom
Abstract
The prevalence and severity of non-alcoholic fatty liver disease (NAFLD) is increasing, yet adequately validated tests for care paths are limited and non-invasive markers of disease progression are urgently needed. The aim of this work was to summarize the performance of Pro-C3, a biomarker of active fibrogenesis, in detecting significant fibrosis (F ≥ 2), advanced fibrosis (F ≥ 3), cirrhosis (F4) and non-alcoholic steatohepatitis (NASH) in patients with NAFLD. A sensitive search of five databases was performed in July 2021. Studies reporting Pro-C3 measurements and liver histology in adults with NAFLD without co-existing liver diseases were eligible. Meta-analysis was conducted by applying a bivariate random effects model to produce summary estimates of Pro-C3 accuracy. From 35 evaluated reports, eight studies met our inclusion criteria; 1568 patients were included in our meta-analysis of significant fibrosis and 2058 in that of advanced fibrosis. The area under the summary curve was 0.81 (95% CI 0.77–0.84) in detecting significant fibrosis and 0.79 (95% CI 0.73–0.82) for advanced fibrosis. Our results support Pro-C3 as an important candidate biomarker for non-invasive assessment of liver fibrosis in NAFLD. Further direct comparisons with currently recommended non-invasive tests will demonstrate whether Pro-C3 panels can outperform these tests, and improve care paths for patients with NAFLD.
Citation
Mak, A. L., Lee, J., van Dijk, A.-M., Vali, Y., Aithal, G. P., Schattenberg, J. M., Anstee, Q. M., Brosnan, M. J., Zafarmand, M. H., Ramsoekh, D., Harrison, S. A., Nieuwdorp, M., Bossuyt, P. M., & Holleboom, A. G. (2021). Systematic Review with Meta-Analysis: Diagnostic Accuracy of Pro-C3 for Hepatic Fibrosis in Patients with Non-Alcoholic Fatty Liver Disease. Biomedicines, 9(12), Article 1920. https://doi.org/10.3390/biomedicines9121920
Journal Article Type | Article |
---|---|
Acceptance Date | Dec 10, 2021 |
Online Publication Date | Dec 15, 2021 |
Publication Date | Dec 15, 2021 |
Deposit Date | Jan 4, 2022 |
Publicly Available Date | Jan 6, 2022 |
Journal | Biomedicines |
Electronic ISSN | 2227-9059 |
Publisher | MDPI |
Peer Reviewed | Peer Reviewed |
Volume | 9 |
Issue | 12 |
Article Number | 1920 |
DOI | https://doi.org/10.3390/biomedicines9121920 |
Keywords | General Biochemistry, Genetics and Molecular Biology; Medicine (miscellaneous) |
Public URL | https://nottingham-repository.worktribe.com/output/7163593 |
Publisher URL | https://www.mdpi.com/2227-9059/9/12/1920 |
Files
Biomedicines-1472745
(970 Kb)
PDF
Publisher Licence URL
https://creativecommons.org/licenses/by/4.0/
You might also like
Structuring white rice with gellan gum reduces the glycemic response in healthy humans
(2024)
Journal Article
Downloadable Citations
About Repository@Nottingham
Administrator e-mail: discovery-access-systems@nottingham.ac.uk
This application uses the following open-source libraries:
SheetJS Community Edition
Apache License Version 2.0 (http://www.apache.org/licenses/)
PDF.js
Apache License Version 2.0 (http://www.apache.org/licenses/)
Font Awesome
SIL OFL 1.1 (http://scripts.sil.org/OFL)
MIT License (http://opensource.org/licenses/mit-license.html)
CC BY 3.0 ( http://creativecommons.org/licenses/by/3.0/)
Powered by Worktribe © 2025
Advanced Search